Number of the records: 1

cetuximab

SYS		d000068818
LBL		00000nx^^^2200181-^^45^^
005		20240119200757.2
100		$a 20160101asloy0103 ba0
152		$b mesh
250		$a cetuximab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo
300	1-	$a 2016 (2000) $8 eng
330	1-	$a A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors. $8 eng
450		$a C225 $5 e $8 slo
550		$3 sllk_un_auth*d066246 $Y ErbB Receptors $5 F $a receptory erbB
686		$a D12.776.124.486.485.114.224.060.750
686		$a D12.776.124.790.651.114.224.060.750
686		$a D12.776.377.715.548.114.224.200.750
750		$a Cetuximab $8 eng
801	-0	$a SK $b BA006 $c 20160207
801	-2	$a SK $b BA006 $c 20160209
980		$x M

Number of the records: 1